CRL
NYSE HealthcareCharles River Laboratories International, Inc. Common Stock
Diagnostics & Research
📊 Market Data
| Price | $152.66 |
|---|---|
| Volume | 1,168,123 |
| Market Cap | 7.52B |
| Beta | 1.650 |
| RSI (14-Day) | 37.7 |
| 200-Day MA | $172.55 |
| 50-Day MA | $192.94 |
| 52-Week High | $228.88 |
| 52-Week Low | $91.86 |
| Forward P/E | 12.46 |
| Price / Book | 2.37 |
🎯 Investment Strategy Scores
How CRL scores across each investment strategy. Higher is better for that strategy's goals.
💰 Dividend Daddy
10/100
High dividend yield + low volatility
🚀 Moon Shot
84/100
High growth potential (high beta + oversold)
🔪 Falling Knife
65/100
Contrarian plays (oversold + below moving average)
🎈 Over-Hyped
48/100
Overbought stocks (potential short candidates)
🐋 Institutional Whale
68/100
Large-cap, institutional-quality stocks
Find CRL in your text
Paste any text on the homepage — the tool will extract CRL and other hidden tickers.
Disclaimer: This data is for educational and entertainment purposes only and does not constitute financial advice. Market data may be delayed. Always do your own research before making investment decisions.